Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale President and CEO sold 43,168 shares at $7.82 ($337,574)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale President and CEO sold 62,073 shares at $7.00 ($434,511)
  8. 4 Open-market sale See remarks sold 40,529 shares at an average $7.40 ($299,949)
  9. 4 Open-market sale Chief Financial Officer sold 21,664 shares at $7.29 ($157,931)
  10. 4 Open-market sale President, R&D sold 30,897 shares at $7.29 ($225,239)
  11. 4 Open-market sale See remarks sold 17,083 shares at an average $3.68 ($62,947)
  12. 4 Open-market sale Chief Financial Officer sold 20,081 shares at an average $3.69 ($74,000)
  13. 4 Open-market sale President, R&D sold 30,770 shares at an average $3.69 ($113,478)
  14. 4 Open-market sale Chief Legal Officer sold 19,913 shares at an average $3.68 ($73,378)
  15. 4 Open-market sale President and CEO sold 61,379 shares at $3.57 ($219,123)
  16. 4 Grant or award See remarks acquired 5,000 shares (grant or award)
  17. 4 Grant or award President and CEO acquired 5,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 3 of 16 · 320 filings